retatrutide and addiction Is a new weight-loss drug making people fall out of love? | Weight-loss drugs Eli Lilly gave mysterious access

There are documented case reports of extreme appetite suppression and psychiatric complications requiring GLP-1 discontinuation in people with restrictive eating patterns ( Leziak et al., J Psychiatric Research, 2026 )

A physical examination, medical history, diagnostic tests, and an evaluation of the persons health risks associated with their weight are a part of this process

Compounded semaglutide products provided by Noom are not FDA-approved, are unavailable in all 50 US states, and compounded medication ships with 7-day delivery

In several cases, the page displayed a doctor headshot while the ad itself featured an unrelated person delivering a patient testimonial

This is a key difference from Zepbound (tirzepatide), whose FDA prescribing information explicitly restricts the upper arm to caregiver administration

It comes in a pre-filled, single-use autoinjector pen, making it convenient for patients